RE:RE:RE:RE:RE:RE:RE:Prothena and Management's Reporting Give us your take on Prothena.
Does xB3 work well enough to do business?
Why are the deals so small?
You can suggest whatever you want about my motives but it doesn't change the state that Bioasis is in.
You could have said all of that re Shire years ago.
If a company chooses to move forward, we'll hear about it. Otherwise, they just fade from mention in the docs. I'm not overly thrilled about the lack of commication, but that's just the way it's usually done. But talking about Regulars? That's a wee bit over the line and would go no where.
Over the years, you've criticized people who have bashed their BTI investment. So now that you're out, it's OK?